ticlopidine has been researched along with Hemolytic-Uremic Syndrome in 15 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Hemolytic-Uremic Syndrome: A syndrome that is associated with microvascular diseases of the KIDNEY, such as RENAL CORTICAL NECROSIS. It is characterized by hemolytic anemia (ANEMIA, HEMOLYTIC); THROMBOCYTOPENIA; and ACUTE RENAL FAILURE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Of 72 children with diarrhea associated hemolytic uremic syndrome, 88% were treated with platelet aggregation inhibitors (clopidogrel 56%, sulfinpyrazone 19%, dipyridamole 13%)." | 9.16 | Efficacy and safety of clopidogrel in children with diarrhea associated hemolytic uremic syndrome. ( Bakel, LA; Cadnapaphornchai, MA; Ford, D; Gao, D; Lum, G; Seltz, LB; Tiehen, J, 2012) |
| "Of 72 children with diarrhea associated hemolytic uremic syndrome, 88% were treated with platelet aggregation inhibitors (clopidogrel 56%, sulfinpyrazone 19%, dipyridamole 13%)." | 5.16 | Efficacy and safety of clopidogrel in children with diarrhea associated hemolytic uremic syndrome. ( Bakel, LA; Cadnapaphornchai, MA; Ford, D; Gao, D; Lum, G; Seltz, LB; Tiehen, J, 2012) |
| "Hemolytic uremic syndrome (HUS), thrombotic thrombocytopenic purpura (TTP), and several other conditions are associated with TMA." | 2.44 | The thrombotic microangiopathies. ( Copelovitch, L; Kaplan, BS, 2008) |
| "Drug-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome (TTP/HUS) has been recognized for several years." | 2.43 | Drug-induced thrombotic microangiopathy. ( Bennett, C; Zakarija, A, 2005) |
| "Ticlopidine therapy is an important risk factor for TTP." | 2.41 | Thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. ( Baker, KR; Moake, JL, 2000) |
| "Ticlopidine has been reported to have major hematologic adverse effects, including neutropenia and thrombotic thrombocytopenic purpura or hemolytic uremic syndrome (HUS)." | 1.31 | Hemolytic uremic syndrome associated with clopidogrel: a case report. ( Marcoux, JP; Moy, B; Raffel, GD; Wang, JC, 2000) |
| "We present a case report of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS) developing in a kidney/pancreas transplant recipient after the initiation of treatment with clopidogrel for symptomatic coronary artery disease." | 1.31 | Clopidogrel-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in a kidney/pancreas transplant recipient. ( Chinnakotla, S; Fidler, ME; Hammeke, MD; Leone, JP; Tarantolo, S, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 14 (93.33) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Seltz, LB | 1 |
| Bakel, LA | 1 |
| Tiehen, J | 1 |
| Gao, D | 1 |
| Cadnapaphornchai, MA | 1 |
| Lum, G | 1 |
| Ford, D | 1 |
| Griffiths, C | 1 |
| Fisher, M | 1 |
| Evens, AM | 1 |
| Kwaan, HC | 1 |
| Kaufman, DB | 1 |
| Bennett, CL | 1 |
| Manor, SM | 1 |
| Guillory, GS | 1 |
| Jain, SP | 1 |
| Andersohn, F | 1 |
| Hagmann, FG | 1 |
| Garbe, E | 1 |
| Szułdrzyński, K | 1 |
| Dropiński, J | 1 |
| Szczeklik, W | 1 |
| Zakarija, A | 1 |
| Bennett, C | 1 |
| Yagi, H | 1 |
| Matsumoto, M | 1 |
| Fujimura, Y | 1 |
| Copelovitch, L | 1 |
| Kaplan, BS | 1 |
| Baker, KR | 1 |
| Moake, JL | 1 |
| Moy, B | 1 |
| Wang, JC | 1 |
| Raffel, GD | 1 |
| Marcoux, JP | 1 |
| Oomen, PH | 1 |
| Tulleken, JE | 1 |
| Zijlstra, JG | 1 |
| Chinnakotla, S | 1 |
| Leone, JP | 1 |
| Fidler, ME | 1 |
| Hammeke, MD | 1 |
| Tarantolo, S | 1 |
| Mauro, M | 1 |
| Kim, J | 1 |
| Costello, C | 1 |
| Laurence, J | 1 |
| Medina, PJ | 1 |
| Sipols, JM | 1 |
| George, JN | 1 |
5 reviews available for ticlopidine and Hemolytic-Uremic Syndrome
| Article | Year |
|---|---|
Drug-induced thrombotic microangiopathy.
Topics: ADAM Proteins; ADAMTS13 Protein; Antibiotics, Antineoplastic; Cyclosporine; Endothelium, Vascular; F | 2005 |
[Brain nerve symptoms due to thrombotic microangiopathy].
Topics: ADAM Proteins; ADAMTS13 Protein; Adult; Aged; Aged, 80 and over; Cerebrovascular Disorders; Clopidog | 2007 |
The thrombotic microangiopathies.
Topics: Hematopoietic Stem Cell Transplantation; Hemolytic-Uremic Syndrome; HIV Infections; Humans; Lupus Er | 2008 |
Thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
Topics: Anti-Bacterial Agents; Child; Diagnosis, Differential; Erythropoietin; Hemolytic-Uremic Syndrome; Hu | 2000 |
Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
Topics: Antibiotics, Antineoplastic; Clopidogrel; Cyclosporine; Hemolytic-Uremic Syndrome; Humans; Immunosup | 2001 |
1 trial available for ticlopidine and Hemolytic-Uremic Syndrome
| Article | Year |
|---|---|
Efficacy and safety of clopidogrel in children with diarrhea associated hemolytic uremic syndrome.
Topics: Adolescent; Child; Child, Preschool; Clopidogrel; Diarrhea; Female; Hemolytic-Uremic Syndrome; Human | 2012 |
9 other studies available for ticlopidine and Hemolytic-Uremic Syndrome
| Article | Year |
|---|---|
Abciximab-induced thrombocytopenia.
Topics: Abciximab; Antibodies, Monoclonal; Anticoagulants; Clopidogrel; Diagnosis, Differential; Hemolytic-U | 2002 |
TTP/HUS occurring in a simultaneous pancreas/kidney transplant recipient after clopidogrel treatment: evidence of a nonimmunological etiology.
Topics: Calcineurin; Clopidogrel; Graft Rejection; Hemolytic-Uremic Syndrome; Humans; Kidney Transplantation | 2002 |
Clopidogrel-induced thrombotic thrombocytopenic purpura-hemolytic uremic syndrome after coronary artery stenting.
Topics: Clopidogrel; Coronary Disease; Hemolytic-Uremic Syndrome; Humans; Male; Middle Aged; Platelet Aggreg | 2004 |
Thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome associated with clopidogrel: report of two new cases.
Topics: Adult; Aged; Angina Pectoris; Carotid Artery, Internal; Carotid Stenosis; Clopidogrel; Hemolytic-Ure | 2004 |
[Thrombotic thrombocytopenic purpura -- a rare complication associated with clopidogrel therapy. A case report].
Topics: Clopidogrel; Female; Hemolytic-Uremic Syndrome; Humans; Middle Aged; Platelet Aggregation Inhibitors | 2005 |
Hemolytic uremic syndrome associated with clopidogrel: a case report.
Topics: Angina, Unstable; Clopidogrel; Hemolytic-Uremic Syndrome; Humans; Male; Middle Aged; Plasmapheresis; | 2000 |
Hemolytic uremic syndrome in a patient treated with clopidogrel.
Topics: Aged; Clopidogrel; Hemolytic-Uremic Syndrome; Humans; Male; Myocardial Infarction; Platelet Aggregat | 2000 |
Clopidogrel-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in a kidney/pancreas transplant recipient.
Topics: Adult; Clopidogrel; Coronary Disease; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathie | 2000 |
Role of transforming growth factor beta1 in microvascular endothelial cell apoptosis associated with thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome.
Topics: Apoptosis; Cell Cycle; Cell Lineage; Cells, Cultured; Coronary Vessels; Culture Media, Serum-Free; E | 2001 |